---
document_datetime: 2025-12-02 06:49:59
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/daronrix.html
document_name: daronrix.html
version: success
processing_time: 0.0942191
conversion_datetime: 2025-12-24 16:39:01.05565
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Daronrix

[RSS](/en/individual-human-medicine.xml/66929)

##### Lapsed

This medicine's authorisation has lapsed

pandemic influenza vaccine (whole virion, inactivated, adjuvanted) Medicine Human Lapsed

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 21 March 2007, the European Commission granted a marketing authorisation valid throughout the European Union (EU) for the medicinal product Daronrix (pandemic influenza vaccine (H5N1) (whole virion, inactivated, adsorbed)), indicated for the prophylaxis of influenza in an officially declared pandemic situation. The marketing authorisation holder was notified on the 23 March 2007.

Daronrix (pandemic influenza vaccine (H5N1) (whole virion, inactivated, adsorbed)) has not been marketed in Europe since this initial marketing authorisation. In accordance with article 14(4) of Regulation (EC) No 726/2004 ('sunset clause'), the marketing authorisation of a medicinal product lapses if the product has never been marketed in one of the Member States within three years of its initial authorisation.

Because of this, the marketing authorisation for Daronrix is no longer valid. The Marketing Authorisation Holder of Daronrix has confirmed that the product was not marketed due to lack of demand for this vaccine.

Pursuant to the expiry of the marketing authorisation, the European Assessment Report (EPAR) for Daronrix is updated to reflect that the marketing authorisation is no longer valid.

Daronrix : EPAR - Summary for the public

English (EN) (192.55 KB - PDF)

**First published:** 11/04/2007

**Last updated:** 02/07/2013

[View](/en/documents/overview/daronrix-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-889)

български (BG) (384.73 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/bg/documents/overview/daronrix-epar-summary-public_bg.pdf)

español (ES) (183.83 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/es/documents/overview/daronrix-epar-summary-public_es.pdf)

čeština (CS) (348.3 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/cs/documents/overview/daronrix-epar-summary-public_cs.pdf)

dansk (DA) (182.9 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/da/documents/overview/daronrix-epar-summary-public_da.pdf)

Deutsch (DE) (185.45 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/de/documents/overview/daronrix-epar-summary-public_de.pdf)

eesti keel (ET) (178.95 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/et/documents/overview/daronrix-epar-summary-public_et.pdf)

ελληνικά (EL) (383.32 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/el/documents/overview/daronrix-epar-summary-public_el.pdf)

français (FR) (184.47 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/fr/documents/overview/daronrix-epar-summary-public_fr.pdf)

italiano (IT) (183.55 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/it/documents/overview/daronrix-epar-summary-public_it.pdf)

latviešu valoda (LV) (387.16 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/lv/documents/overview/daronrix-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (325.44 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/lt/documents/overview/daronrix-epar-summary-public_lt.pdf)

magyar (HU) (339.88 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/hu/documents/overview/daronrix-epar-summary-public_hu.pdf)

Malti (MT) (392.73 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/mt/documents/overview/daronrix-epar-summary-public_mt.pdf)

Nederlands (NL) (183.66 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/nl/documents/overview/daronrix-epar-summary-public_nl.pdf)

polski (PL) (399.29 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/pl/documents/overview/daronrix-epar-summary-public_pl.pdf)

português (PT) (183.97 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/pt/documents/overview/daronrix-epar-summary-public_pt.pdf)

română (RO) (323.65 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/ro/documents/overview/daronrix-epar-summary-public_ro.pdf)

slovenčina (SK) (350.6 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/sk/documents/overview/daronrix-epar-summary-public_sk.pdf)

slovenščina (SL) (326.67 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/sl/documents/overview/daronrix-epar-summary-public_sl.pdf)

Suomi (FI) (179.34 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/fi/documents/overview/daronrix-epar-summary-public_fi.pdf)

svenska (SV) (179.51 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/sv/documents/overview/daronrix-epar-summary-public_sv.pdf)

## Product information

Daronrix : EPAR - Product Information

English (EN) (634.97 KB - PDF)

**First published:** 11/04/2007

**Last updated:** 02/07/2013

[View](/en/documents/product-information/daronrix-epar-product-information_en.pdf)

[Other languages (13)](#file-language-dropdown-386)

български (BG) (1 MB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/bg/documents/product-information/daronrix-epar-product-information_bg.pdf)

español (ES) (634.33 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/es/documents/product-information/daronrix-epar-product-information_es.pdf)

čeština (CS) (713.58 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/cs/documents/product-information/daronrix-epar-product-information_cs.pdf)

dansk (DA) (601.39 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/da/documents/product-information/daronrix-epar-product-information_da.pdf)

Deutsch (DE) (591.25 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/de/documents/product-information/daronrix-epar-product-information_de.pdf)

eesti keel (ET) (624.03 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/et/documents/product-information/daronrix-epar-product-information_et.pdf)

ελληνικά (EL) (799.06 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/el/documents/product-information/daronrix-epar-product-information_el.pdf)

français (FR) (657.41 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/fr/documents/product-information/daronrix-epar-product-information_fr.pdf)

italiano (IT) (521.62 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/it/documents/product-information/daronrix-epar-product-information_it.pdf)

latviešu valoda (LV) (733.4 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/lv/documents/product-information/daronrix-epar-product-information_lv.pdf)

lietuvių kalba (LT) (666.14 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/lt/documents/product-information/daronrix-epar-product-information_lt.pdf)

magyar (HU) (666.77 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/hu/documents/product-information/daronrix-epar-product-information_hu.pdf)

Suomi (FI) (640.98 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/fi/documents/product-information/daronrix-epar-product-information_fi.pdf)

21/03/2007

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Daronrix : EPAR - All Authorised presentations

English (EN) (139.62 KB - PDF)

**First published:** 11/04/2007

**Last updated:** 02/07/2013

[View](/en/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_en.pdf)

[Other languages (22)](#file-language-dropdown-133)

български (BG) (224.75 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/bg/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_bg.pdf)

español (ES) (143.12 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/es/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_es.pdf)

čeština (CS) (220.6 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/cs/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (143.24 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/da/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (143.07 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/de/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (140.49 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/et/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (226.28 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/el/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_el.pdf)

français (FR) (143.25 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/fr/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_fr.pdf)

íslenska (IS) (140.52 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/is/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_is.pdf)

italiano (IT) (139.76 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/it/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (216.85 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/lv/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (211.85 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/lt/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (216.97 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/hu/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_hu.pdf)

Nederlands (NL) (142.82 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/nl/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (142.91 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/no/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_no.pdf)

polski (PL) (220.44 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/pl/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_pl.pdf)

português (PT) (142.99 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/pt/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_pt.pdf)

română (RO) (208.99 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/ro/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (216.7 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/sk/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (187.52 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/sl/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (140.1 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/fi/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (143.26 KB - PDF)

**First published:**

11/04/2007

**Last updated:**

02/07/2013

[View](/sv/documents/all-authorised-presentations/daronrix-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Daronrix Active substance whole virion, inactivated, containing antigen*: A/Vietnam/1194/2004 (H5N1)* produced in eggs International non-proprietary name (INN) or common name pandemic influenza vaccine (whole virion, inactivated, adjuvanted) Therapeutic area (MeSH)

- Influenza, Human
- Immunization
- Disease Outbreaks

Anatomical therapeutic chemical (ATC) code J07BB01

### Pharmacotherapeutic group

Vaccines

### Therapeutic indication

Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with official guidance.

## Authorisation details

EMA product number EMEA/H/C/000706

Exceptional circumstances

This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see [Pre-authorisation guidance](/node/68554) .

Marketing authorisation holder

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut, 89

Marketing authorisation issued 21/03/2007 Lapse of marketing authorisation 24/06/2013

## Assessment history

## Initial marketing authorisation documents

Daronrix : EPAR - Scientific Discussion

English (EN) (1017.83 KB - PDF)

**First published:** 11/04/2007

**Last updated:** 02/07/2013

[View](/en/documents/scientific-discussion/daronrix-epar-scientific-discussion_en.pdf)

Daronrix : EPAR - Procedural steps taken before authorisation

English (EN) (149.12 KB - PDF)

**First published:** 11/04/2007

**Last updated:** 02/07/2013

[View](/en/documents/procedural-steps/daronrix-epar-procedural-steps-taken-authorisation_en.pdf)

**This page was last updated on** 02/07/2013

## Share this page

[Back to top](#main-content)